Skip to content

Vitros 6199974

by Ortho-Clinical Diagnostics

Vitros 6199974 is a Class II device made by Ortho-Clinical Diagnostics, granted FDA De Novo DEN210038 on 5 May 2023 and listed in FDA GUDID since 22 Nov 2023 (UDI-DI 10758750034550), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

De Novo DEN210038

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10758750034550 UDI-DI Date22 Nov 2023ListedStatusListed GUDID: in commercial distribution
United StatesFDA De NovoDENG from GUDID De Novo granted · Direct NumberDEN210038 Date5 May 2023DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA De Novo DEN210038 decided 5 May 2023 Active
  • FDA GUDID UDI-DI 10758750034550 listed 22 Nov 2023 Listed

Timeline

2 dated events

  1. Granted FDA De Novo DEN210038
  2. Listed FDA GUDID 10758750034550

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

GUDID

Trade name
Vitros
Generic name
SARS-CoV-2 immunoglobulin G (IgG) antibody IVD, control
Model / Ref / Catalog
6199974
Primary DI / UDI-DI
10758750034550
De Novo Number
FDA product code
QVP
GMDN term
SARS-CoV-2 immunoglobulin G (IgG) antibody IVD, control
Device class
Class II
Regulation number
866.3983
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code QVP (SARS-CoV-2 serology test).

Other devices from Ortho-Clinical Diagnostics

See all devices from Ortho-Clinical Diagnostics →

Properties

  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (10, all answered No)